Your browser doesn't support javascript.
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant.
Li, Gen; Zhou, Zhongcheng; Du, Peng; Zhan, Meixiao; Li, Ning; Xiong, Xinxin; Tang, Shengjun; Man, Miao; Baptista-Hon, Daniel T; Lu, Ligong.
  • Li G; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Zhou Z; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Du P; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Zhan M; Zhuhai Precision Medicine Center, Zhuhai People's Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technology, Zhuhai, Guangdong, China.
  • Li N; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Xiong X; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Tang S; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Man M; Zhuhai Precision Medicine Center, Zhuhai People's Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technology, Zhuhai, Guangdong, China.
  • Baptista-Hon DT; Department of Bioinformatics and AI, Guangzhou Laboratory, Guangzhou, China.
  • Lu L; University Hospital and Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Taipa, 999078, Macau, China.
Signal Transduct Target Ther ; 7(1): 243, 2022 07 19.
Article in English | MEDLINE | ID: covidwho-1937417

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01062-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01062-3